THIS IS ONLY THE FIRST INNING.
Shorts don't have a clue.
They will claim that this is all a fraud until the stock is $5.
Then at $5, they will say that it isn't a fraud but is overhyped and overvalued. They might even short more and then watch it go to $10.
The shorts will not really understand or believe any of this until they see the actual reported #'s for the June quarter which will be reported sometime in August (which should be BLOWOUT #'s). Normally, once the company reports blow out #'s in August, the shorts would then say that the financials are manipulated, but we have Deloitte on our side! So they won't be able to do anything but cover. That will take the stock price from $10 to $20.
All of this sounds crazy for a $1 stock but I sincerely believe that we are looking at a $5 stock within the next few months, then NASDAQ, then a $10 stock and then Wall St investment bankers will start coming out with research reports and $25 price targets for 2021. AND then we get to start talking about their CANCER deal and a whole bunch of other great stuff!
This stock is a better buy right now at $1.25 than it was before at $0.50.
Market Data 
Markets 
AI
